Teva Pharmaceutical Industries Limited Board of Directors

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Mr. Richard D. Francis

Mr. Richard D. Francis

President, CEO & Director

Mr. David R. Mcavoy J.D.

Mr. David R. Mcavoy J.D.

Executive VP & Chief Legal Officer

Mr. Christopher J. Stevo CFA

Mr. Christopher J. Stevo CFA

Senior Vice President of Investor Relations & Competitive Intelligence

Kathleen Veit

Kathleen Veit

Senior Vice President, Global Compliance & Ethics Officer

Mr. Richard Gordon Daniell

Mr. Richard Gordon Daniell

Executive Vice President of European Commercial

Mr. Mark Sabag

Mr. Mark Sabag

Executive Vice President of International Markets Commercial

Mr. Placid Jover

Mr. Placid Jover

Executive VP & CHRO

Mr. Amir Weiss

Mr. Amir Weiss

Senior VP & Chief Accounting Officer

Mr. Matthew Shields

Mr. Matthew Shields

Executive Vice President of Global Operations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.